Alpine Immune Sciences (ALPN) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Alpine Immune Sciences (ALPN) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: September 20, 2024 (18:26)

Sector: Healthcare

The share price of Alpine Immune Sciences, Inc. (ALPN) now

This company is DELISTED
Latest session on the 9th of September for
Alpine Immune Sciences, Inc. is negative
Trading Volume: 2
Open: 64.97 /  High: 64.97 /  Low: 64.97
What analysts predict: $62
52-week High/Low: $64.97 / $8.33
50-Day Moving Average: $53.15 — support level today
200-Day Moving Average: $26.84 — support level today

Are you interested in Alpine Immune Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alpine Immune Sciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Alpine Immune Sciences share be worth in 2024 - 2028?

When should I take profit in Alpine Immune Sciences stock? When should I record a loss on Alpine Immune Sciences stock? What are analysts' forecasts for Alpine Immune Sciences stock? What is the future of Alpine Immune Sciences stock? We forecast Alpine Immune Sciences stock performance using neural networks based on historical data on Alpine Immune Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Alpine Immune Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alpine Immune Sciences shares. This happens once a day.


Historical and forecast chart of Alpine Immune Sciences stock

The chart below shows the historical price of Alpine Immune Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alpine Immune Sciences stock price can be found in the table below.

No data

Long-term forecasts by years.

Alpine Immune Sciences, Inc. Is a biopharmaceutical company. The company is focused on the discovery and development of protein immunotherapy for the treatment of cancer, autoimmune and inflammatory diseases. The Company’s scientific platform uses a directed evolutionary process to convert native immune system proteins from the immunoglobulin superfamily (IgSF) into multipurpose therapeutic drugs capable of modulating the human immune system. Its candidate products include ALPN-101, ALPN-202 and ALPN-303. ALPN-101 is a dual inducible T cell costimulant (ICOS) and differentiation cluster 28 (CD28) antagonist for the treatment of autoimmune and inflammatory diseases. His cancer program is ALPN-202, a conditional CD28 co-stimulator and dual checkpoint inhibitor for cancer treatment. ALPN-303 is a dual antagonist of B-cell cytokines for the treatment of B-cell mediated diseases.

Trending Themes in the Healthcare Sector

Alpine Immune Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Sep 22 65.52 64.03 66.09 3.22
Sep 23 66.43 65.13 67.58 3.76
Sep 24 66.79 65.87 68.21 3.56
Sep 25 65.32 64.68 66.07 2.15
Sep 26 65.52 64.79 66.60 2.79
Sep 27 67.27 66.32 67.98 2.50
Sep 28 67.51 66.54 68.24 2.56
Sep 29 68.16 66.63 69.39 4.14
Sep 30 67.20 66.31 68.03 2.58
Oct 01 67.22 66.31 68.61 3.47
Oct 02 65.99 64.78 66.76 3.06
Oct 03 66.38 65.19 66.88 2.60
Oct 04 65.43 65.02 66.00 1.51
Oct 05 64.82 63.87 66.14 3.56
Oct 06 65.40 64.30 66.42 3.30
Oct 07 66.03 65.54 66.43 1.36
Oct 08 66.69 65.93 67.85 2.91
Oct 09 66.53 65.03 68.04 4.63
Oct 10 66.35 65.75 67.28 2.33
Oct 11 64.43 62.89 65.58 4.27
Oct 12 64.36 63.28 65.40 3.36
Oct 13 62.93 61.95 63.84 3.05
Oct 14 63.55 63.15 64.98 2.90
Oct 15 64.92 63.64 66.19 4.01
Oct 16 66.54 65.36 67.56 3.36
Oct 17 68.00 66.59 68.86 3.40
Oct 18 66.31 65.59 66.72 1.73
Oct 19 65.29 64.43 66.74 3.59
Oct 20 64.76 63.89 65.97 3.25
Oct 21 65.58 64.34 66.31 3.06

Alpine Immune Sciences Daily Price Targets


Alpine Immune Sciences Stock Forecast 09-22-2024.

Forecast target price for 09-22-2024: $65.52.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.123%.
Pessimistic target level: 64.03
Optimistic target level: 66.09

Alpine Immune Sciences Stock Forecast 09-23-2024.

Forecast target price for 09-23-2024: $66.43.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.627%.
Pessimistic target level: 65.13
Optimistic target level: 67.58

Alpine Immune Sciences Stock Forecast 09-24-2024.

Forecast target price for 09-24-2024: $66.79.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 3.437%.
Pessimistic target level: 65.87
Optimistic target level: 68.21

Alpine Immune Sciences Stock Forecast 09-25-2024.

Forecast target price for 09-25-2024: $65.32.
Negative dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 2.106%.
Pessimistic target level: 64.68
Optimistic target level: 66.07

Alpine Immune Sciences Stock Forecast 09-26-2024.

Forecast target price for 09-26-2024: $65.52.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 2.715%.
Pessimistic target level: 64.79
Optimistic target level: 66.60

Alpine Immune Sciences Stock Forecast 09-27-2024.

Forecast target price for 09-27-2024: $67.27.
Positive dynamics for Alpine Immune Sciences shares will prevail with possible volatility of 2.434%.
Pessimistic target level: 66.32
Optimistic target level: 67.98

ALPN (ALPN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Oct. 74.95 69.43 83.22 16.57
Nov. 74.71 72.20 77.94 7.36
Dec. 71.60 68.62 76.87 10.73

Alpine Immune Sciences forecast for this year


Alpine Immune Sciences Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $74.9494. Pessimistic: $69.43. Optimistic: $83.22


Alpine Immune Sciences Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $74.7096. Pessimistic: $72.20. Optimistic: $77.94


Alpine Immune Sciences Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $71.6016. Pessimistic: $68.62. Optimistic: $76.87



Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 75.38 71.52 81.77 12.54
Feb 66.70 62.00 70.97 12.63
Mar 76.73 67.03 82.87 19.11
Apr 79.55 70.01 85.28 17.91
May 77.26 72.32 83.94 13.84
Jun 71.95 63.54 77.93 18.46
Jul 71.83 67.81 78.38 13.49
Aug 71.26 63.05 74.68 15.57
Sep 70.80 66.84 75.56 11.54
Oct 71.37 67.26 74.11 9.25
Nov 76.39 67.22 82.99 19.00
Dec 72.11 67.84 76.61 11.45

Alpine Immune Sciences (ALPN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 81.00 76.59 90.72 15.57
Feb 76.59 70.22 79.17 11.30
Mar 71.69 68.02 74.67 8.91
Apr 82.36 73.00 88.29 17.31
May 84.60 80.40 95.43 15.74
Jun 86.22 79.74 93.26 14.50
Jul 81.94 77.36 89.55 13.62
Aug 85.48 79.47 93.55 15.06
Sep 86.99 81.14 93.67 13.37
Oct 95.90 86.38 101.42 14.83
Nov 94.36 89.08 98.74 9.79
Dec 87.72 78.04 93.33 16.39

Alpine Immune Sciences information and performance

Alpine Immune Sciences Address

201 ELLIOTT AVE. WEST, SUITE 230, SEATTLE, WA, US

Market Capitalization: 4 456 780 000 $

Market capitalization of the Alpine Immune Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALPN shares in the company outstanding by the market price of one share.

EBITDA: -50 771 000 $

EBITDA of Alpine Immune Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.64

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.251
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 66.29

Enterprise Value (EV) /Revenue

EV To EBITDA: -124.26

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 68598000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Alpine Immune Sciences (ALPN) stock dividend

Alpine Immune Sciences last paid dividends on 01/01/1970. The next scheduled payment will be on 07/25/2017. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.